Latest News
INmune Bio Inc.
- Form 8K INmune Bio Inc For: 21 October
- Inmune Bio advances Ebstrocel commercialization with Uniphar deal and UK pre-MAA submission
- INmune Bio Establishes Global Commercialization Framework for Ebstrocel™ Through Strategic Agreement with Uniphar
- INmune Bio Inc. (INMB) Sets Uniphar Deal for Ebstrocel Access
- INmune Bio partners with Uniphar for Ebstrocel distribution By Investing.com
- INmune Bio submits pre-approval package to UK regulator for RDEB
- INmune Bio Inc. (INMB) Partners With QCi to Apply Quantum/AI to XPro
- QCi and INmune Bio partner to study XPro in Alzheimer’s
- INmune Bio Inc. (INMB) Partners With QCi to Apply Quantum/AI to XPro
- INmune Bio Inc. and Quantum Computing Inc. Partner to Apply Quantum Optimization and AI to Advance Alzheimer's Drug Research and Explore New Applications for XPro
- INmune Bio and QCi Apply Quantum Optimization to XPro Research
- Quantum Computing Inc Expands Into Pharma With INmune Bio Deal
Headlines from the last 30 days, linking to the original publishers. See all market news →